Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cabaletta Bio, Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-01 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-01
Exact text from the filing
The votes cast at the Annual Meeting were as follows: For Against Abstain Broker Non-Votes 27,268,632 5,343 9,170 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cabaletta Bio, Inc. shareholders approved Approval of amendment to the 2019 Plan at the 2023-06-01 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-06-01
Exact text from the filing
The votes cast at the Annual Meeting were as follows: For Against Abstain Broker Non-Votes 21,684,293 3,045,532 12,925 2,540,395
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cabaletta Bio, Inc. shareholders approved Election of Class I director Scott Brun, M.D. at the 2023-06-01 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-01
Exact text from the filing
The votes cast at the Annual Meeting were as follows: For Withheld Broker Non-Votes Scott Brun, M.D. 23,574,643 1,168,107 2,540,395
View on SEC.gov